FDA draft guidance aims to speed personalized gene therapies for rare diseases

FDA draft guidance offers rare disease gene therapy developers clarity on personalized approvals, BLAs, and faster variant updates. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real